Response [orga]
Hormonal [qlco]
treatment [ftcn]
Young [tmco]
Females [fndg]
Primary [qlco]
Very [qlco]
Premature Ovarian Failure [dsyn]
Aim [idcn]
Study [mnob]
To [qlco]
Evaluate [ftcn]
IMPACT [gngm]
hormone treatment [topp]
Several [qnco]
endocrinologic [ftcn]
Metabolic [ftcn]
Bone [bpoc]
Parameters [fndg]
Young [tmco]
Women [popg]
Primary [qlco]
Very [qlco]
Premature Ovarian Failure [dsyn]
Study [mnob]
included [ftcn]
Females [fndg]
Old [tmco]
Primary [qlco]
Secondary amenorrhea [dsyn]
Female external genitalia [bpoc]
Study Subject [grup]
Three [qnco]
Group [idcn]
Group A [clas]
included [ftcn]
Subject [grup]
Turner Syndrome [cgab, dsyn]
Group [idcn]
included [ftcn]
Subject [grup]
swyer syndrome [cgab, dsyn]
Group C [clas]
included [ftcn]
Subject [grup]
Very [qlco]
Premature Ovarian Failure [dsyn]
hormone treatment [topp]
Administered [ftcn]
months [tmco]
included [ftcn]
Conjugated oestrogens [horm, phsu, strd]
medroxyprogesterone acetate [horm, phsu, strd]
Group [idcn]
hormone treatment [topp]
Provided [acty]
Hormonal [qlco]
Profile [lbpr]
Result [ftcn]
Adequate [qlco]
Serum [bdsu]
Oestrogens [horm, phsu, strd]
Levels [qlco]
Group A [clas]
adverse effects [ftcn]
Metabolic [ftcn]
Coagulation [ortf]
Parameters [fndg]
Note [clna]
increases [ftcn]
High Density Lipoprotein Cholesterol [bacs, lipd]
Levels [qlco]
Bone Density [clna]
Observed [ftcn]
Similar [qlco]
effects [qlco]
hormone treatment [topp]
Observed [ftcn]
Group [idcn]
Group C [clas]
adverse effects [ftcn]
hormone treatment [topp]
Note [clna]
Favorable [qlco]
Increase [ftcn]
Absent [qnco]
Bone Density [clna]
Keep [ftcn]
Increasing [ftcn]
month [tmco]
Evaluation [ftcn]
Conclusion [idcn]
Administration [ocac]
hormone treatment [topp]
Young [tmco]
Women [popg]
Primary [qlco]
Very [qlco]
Premature Ovarian Failure [dsyn]
